| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.7M | +31.8% |
| SG&A Expense | $5.7M | +1.4% |
| Operating Income | -$11.4M | -14.5% |
| Net Income | -$10.2M | -3.5% |
| EPS (Basic) | -$0.99 | +9.2% |
| EPS (Diluted) | -$0.99 | +9.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | -73.3% |
| Short-term Investments | $2.0M | +0.0% |
| Total Assets | $1.5M | -79.8% |
| Current Liabilities | $1.2M | +6.6% |
| Total Liabilities | $4.5M | +305.3% |
| Stockholders' Equity | -$3.0M | -148.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.3M | -16.4% |
| Investing Cash Flow | $2.0M | +200.0% |
| Financing Cash Flow | $5.0M | — |